Trump unveils deal to lower prices for breakthrough weight-loss drugs
The deal could expand coverage and lower the price of GLP-1 medications for millions of Americans. The Trump administration has struck a deal with drugmakers Eli Lilly and Novo Nordisk to offer their breakthrough weight-loss medications at steep discounts for certain Medicare and Medicaid patients, President Donald Trump announced at the White House on Thursday. … Read more